News

Awarded 9 million NOK to study autophagy in prostate cancer

Nikolai Engedal
Nikolai Engedal

Nikolai Engedal was recently awarded 9 million NOK in Open project support from The South-Eastern Norway Regional Health Authority (Helse Sør-Øst) 2020 call. The project aims to unravel the role of autophagy in prostate cancer formation and progression, to discover prognostic autophagy-related gene signatures and markers, and to identify autophagy-modulating drugs that can reduce cancer cell aggressiveness. Engedal is now starting up a project group in Eivind Hovig’s group at the Department of Tumor Biology.

AUTOprost grant application funded

The application “AUTOprost – the role of autophagy in prostate cancer formation and progression” to the Open Call of The South-Eastern Norway Regional Health Authority was recently funded with NOK 9 million (principal investigator: Nikolai Engedal). 

(posted January 29th 2021)

The 4th edition of Guidelines for the use and interpretation of assays for monitoring autophagy to appear soon! 

- A new and updated edition of the “Guidelines for the use and interpretation of assays for monitoring autophagy” (4th edition) is now in press in the journal Autophagy. A must read for everyone interested in autophagy! 

(posted January 29th 2021)